Do patients with psoriasis have an increased risk of cardiovascular disease?

In a recent study, researchers who used PET and CT for testing found that patients who have psoriasis have an increased risk of cardiovascular disease. 

Researchers published their findings in the British Journal of Dermatology, with the main objective to find out if there was a relationship between global vascular inflammation and subcutaneous adipose tissue inflammation in patients with psoriasis.

The study was conducted in a university hospital dermatology clinic in Finland testing 12 patients with moderate-to-severe psoriasis and matched controls without psoriasis, age and sex were matched for all. Each underwent FDG-PET/CT for researchers to measure inflammation.

“Global arterial inflammation and subcutaneous inflammation were significantly increased in patients with moderate-to-severe psoriasis compared with controls,” wrote the researchers.

The study was limited due to the small sample size. Larger samples may be tested in order to increase validity of the findings. 

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?